2025-01-30 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Review

**1. Performance Comparison & Summary:**

Colgate-Palmolive Co (CL) is a multinational consumer goods company that manufactures and sells oral hygiene, personal care, home care, and pet nutrition products globally.

The cumulative return of CL (37.66%) significantly underperformed the S&P 500 (VOO) (119.94%) over the analyzed period.  The difference is a substantial -82.3%, placing it at the 5.6th percentile of the historical range of underperformance relative to the S&P 500. This indicates consistent underperformance compared to the broader market.  The provided CAGR data shows varying performance across different periods, with some years showing positive growth and others negative, highlighting the volatility and market dependence.  The beta consistently remains above 0.1, suggesting a higher sensitivity to market movements than the average stock.

**2. Recent Price Movement:**

* **Closing Price:** $89.57
* **5-Day Moving Average:** $89.29
* **20-Day Moving Average:** $88.34
* **60-Day Moving Average:** $91.42

The price is slightly below the 5-day moving average, indicating a recent minor downward trend.  It's also below the 60-day moving average, suggesting a longer-term downtrend.  The 20-day moving average is further below, reinforcing the recent price weakness. The last market price shows a slight decrease of -$0.32 compared to the previous close.  This is a small decrease and doesn't signal a dramatic price shift.

**3. Technical Indicators & Expected Return:**

* **RSI (Relative Strength Index):** 63.98 – Suggests the stock is neither overbought nor oversold, indicating a relatively neutral momentum.
* **PPO (Percentage Price Oscillator):** 0.54 –  A positive value suggests a bullish trend, but the magnitude is relatively small.
* **Relative Divergence (20-day):** +5.6 – Indicates short-term upward momentum relative to the S&P 500, contrasting with the longer-term underperformance.
* **Expected Return:** -790.0% – This extremely negative expected return is concerning and requires further investigation.  It's highly unlikely and suggests a potential error in the calculation or underlying assumptions.  The negative expected return  highlights the significant underperformance compared to the S&P 500, particularly concerning considering a long-term (2+ years) investment.


**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue      |
|------------|--------|---------------|
| 2024-10-25 | $0.90  | $5.03B        |
| 2024-07-26 | $0.89  | $5.06B        |
| 2024-04-26 | $0.83  | $5.07B        |
| 2023-10-27 | $0.86  | $4.92B        |
| 2024-10-25 | $0.86  | $4.92B        | *(Note: Duplicate entry, likely a data error)*


Earnings have been relatively stable in the range of $0.83-$0.90 per share, with slight fluctuations in revenue.  The duplicate entry for October 25, 2024 needs clarification to ensure data accuracy.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue    | Profit Margin |
|-------------|------------|---------------|
| 2024-09-30  | $5.03B     | 61.08%        |
| 2024-06-30  | $5.06B     | 60.62%        |
| 2024-03-31  | $5.07B     | 60.00%        |
| 2023-12-31  | $4.95B     | 59.60%        |
| 2023-09-30  | $4.92B     | 58.54%        |

Revenue has remained relatively consistent, while profit margins have shown a slight downward trend.


**Capital and Profitability:**

| Quarter     | Equity     | ROE           |
|-------------|------------|---------------|
| 2024-09-30  | $0.43B     | 169.43%       |
| 2024-06-30  | $0.12B     | 594.31%       |
| 2024-03-31  | $0.23B     | 296.96%       |
| 2023-12-31  | $0.61B     | 117.90%       |
| 2023-09-30  | -$0.01B    | -7866.67%     |

Equity and ROE show significant volatility and require further investigation, particularly the extremely negative ROE in 2023-Q3. This needs clarification and potential error correction.

**7. Overall Analysis:**

Colgate-Palmolive's performance has lagged the S&P 500 considerably. While recent earnings show stability, the extreme negative expected return (-790%) is a major red flag and likely reflects a significant issue with the provided data. The volatility in equity and ROE figures raises significant concerns regarding the accuracy and reliability of the provided financial information.  The data needs to be thoroughly reviewed and corrected for inconsistencies before drawing definitive conclusions.  Furthermore, the significantly negative expected return requires immediate clarification.  Given the existing inconsistencies, any investment decision should be delayed until the data is validated.


**8. Disclaimer:** This analysis is based on the provided data.  The significant inconsistencies and inaccuracies in the financial data necessitate further investigation before forming any investment opinion.  This is not financial advice.  Consult with a qualified financial advisor before making any investment decisions.
